Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Specific information regarding "Xianglian Shuan" as a distinct drug is not readily available in the provided search results. The name "Xianglian Shuan" (香莲栓) suggests a suppository (栓) formulation of a "Xianglian" (香莲) preparation. "Xianglian" preparations, such as "Xianglian Pill" (香莲丸) or "Xianglian capsule," are traditional Chinese medicines typically composed of Coptidis Rhizoma (Huanglian) and Aucklandiae Radix (Muxiang). These preparations are generally used to treat gastrointestinal diseases, including diarrhea, gastric cancer, and colorectal cancer, by clearing heat, drying dampness, promoting qi circulation, and relieving pain. However, without specific product information for "Xianglian Shuan," its exact composition, mechanism of action, and indications cannot be definitively stated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xianglian Shuan.